NCT06577337 Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants Status RECRUITING Phase PHASE1
NCT06577077 Efficacy/ Safety of Product CM9241GRU in Patients With Perennial Allergic Rhinitis Status NOT_YET_RECRUITING Phase PHASE3
NCT06573281 A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT06572917 Single-dose Prophylactic INdomethacin in Extremely Preterm Infants Status NOT_YET_RECRUITING Phase PHASE2
NCT06571591 Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin Status COMPLETED Phase PHASE3
NCT06571448 Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal Neuralgia Status COMPLETED Phase PHASE2
NCT06570811 Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients Status COMPLETED Phase PHASE2
NCT06570369 A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression Status COMPLETED Phase PHASE1
NCT06569459 Trilaciclib Combined With Concurrent Chemoradiotherapy and Immunotherapy in the Treatment of Esophageal Cancer Status RECRUITING Phase PHASE2
NCT06569355 A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population Status COMPLETED Phase PHASE2
NCT06569212 Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS) Status RECRUITING Phase PHASE4
NCT06568367 Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN) Status RECRUITING Phase PHASE3
NCT06568237 A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atrophy Status RECRUITING Phase PHASE2
NCT06568042 Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06567041 A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 Diabetes Status COMPLETED Phase PHASE1